HTATSF1 antibody - C-terminal region
| Product name: | HTATSF1 antibody - C-terminal region |
| Source: | Rabbit |
| Purity: | >95% |
| Buffer Formulation: | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Applications: | WB |
| Storage: | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| UOM: | 100ug |
Rabbit anti-HTATSF1 polyclonal antibody - C-terminal region
Catalog Number:IC105494
Product Profile
| ProductName | Rabbit anti-HTATSF1 polyclonal antibody - C-terminal region |
|---|---|
| AntibodyType | Primary Antibodies |
| Immunogen |
The immunogen for anti-HTATSF1 antibody: synthetic peptide directed towards the C terminal of human HTATSF1 |
Key Feature
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | |
| Species Reactivity | |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
Target Information
| Gene Symbol | HTATSF1 |
|---|---|
| Gene Synonyms |
TAT-SF1
dJ196E23.2 |
| Gene Full Name | HIV-1 Tat specific factor 1 |
| Gene Summary |
Whereas most DNA sequence-specific transcription factors increase the rate of initiation and interact with enhancer or promoter DNA, human immunodeficiency virus-1 (HIV-1) Tat predominantly stimulates elongation and interacts with the trans-acting responsive (TAR) RNA element. Tat is essential for HIV replication.
More
|
| Alternative Names |
TAT-SF1
dJ196E23.2 |
| MolecularWeight(MW) | 86kDa |
| Sequence | 755 amino acids |
Database Links
| Entrez Gene | 27336 |
|---|---|
| SwissProt ID | O43719 |
| Protein Accession | NP_055315 |
Application
-
Western blot
0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: HepG2 cell lysate
Additional Information
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.
|
|












